Quadcap Wealth Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2009674
Frisco, TX
Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$233,925
New position
Shares Held
707
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quadcap Wealth Management, LLC holds $1,644,593 across 7 Biotechnology names. ALNY ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,891 | $844,407 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
707 | $233,925 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
4,840 | $230,238 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
4,729 | $227,937 | |
| 5 | REPL |
Replimune Group, Inc.
|
10,000 | $76,500 | |
| 6 | OVID |
Ovid Therapeutics Inc.
|
11,111 | $24,666 | |
| 7 | TNYA |
Tenaya Therapeutics, Inc.
|
10,000 | $6,920 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,925 | 707 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||